ArticlePerformance enhancement & health2023
Assessing Canadian regulation of muscle-building supplements: Identifying gaps and recommendations for improvement to protect the health and well-being of young people.
Article in Performance enhancement & health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Regulation of Food Supplements and Pharmacists' Responsibility in Professional Practice: A Review.Pharmacy (Basel, Switzerland) · 2026Review
- Regulatory bodies must critically assess their role in the wellness wave of supplement marketing.Lancet regional health. Americas · 2026Article
- Muscle-building supplement use is associated with muscle dysmorphia symptomatology among Canadian adolescents and young adults.PLOS mental health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Muscle-building supplements are a vast group of dietary products purported to aid with muscle-building and performance enhancement. Legal muscle-building supplements, such as whey protein and creatine monohydrate, are commonly used among young people (i.e., adolescents and young adults ages 10-29 years), particularly boys and young men, and are correlated with many adverse health effects. In Canada, these products are regulated by the Natural Health Products Regulations. This policy analysis aimed to investigate current Canadian policy related to muscle-building supplements to identify key gaps that expose Canadians, particularly young people, to potential risks. Several gaps were identified, including an over-reliance on industry to provide accurate product and manufacturing site testing, no age restrictions on product purchasing and use, no warning labels on products related to known risks, and lack of regulatory control from individual provincial health ministries. Given the gaps, specific policy recommendations are provided to strengthen the current policy, reduce use, and minimize negative effects of use. There is an urgent need to strengthen Canadian regulations of muscle-building supplements to protect the health and well-being of young people.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.